Sexual Health in the News Week of Oct 16- Oct 22

  ·   Link to Article

Other News This Week

This Week
In August, the FDA approved flibanserin, also known as Addyi, for premenopausal women diagnosed with sexual desire dysfunction. Here's how it works and why some are calling it a game changer.
Most women with low sexual desire won't rush to get the first prescription drug to boost female libido when it becomes available on Saturday, but they may have more options down the road.
 
Amidst all the debate about campus sexual assault, there are still questions about the scope of the problem. Two graduate students at Stanford suggest a way to better determine its prevalence. 
 
The US Navy in the past month has seen nine new cases of syphilis in its ranks, as many diagnoses as giardia, Lyme disease and salmonella combined.

Heirs to the Sexual Revolution - New York Magazine
As part of a "Sex on Campus" package, New York Magazine polled more than 700 college students around the country about the hookup and sex cultures on their campuses.
 
Intimate partner violence, or domestic violence, affects one in three women in the US, but among women who also have HIV/AIDS, this incidence climbs to one in two.
 
While Viagra is an FDA-approved drug to treat erectile dysfunction, there are also over-the-counter supplements for sexual enhancement that claim to be "all-natural" or "herbal," but are not approved by the FDA, and do not undergo safety testing.
News Archives

NCSH Fact Sheet

Media Inquiries

For general media inquiries about sexual health topics and/or to schedule an interview with one of our experts, please contact Susan Gilbert, NCSH Co-Director, at susan.gilbert@altarum.org